8th Early Alzheimer s                         Disease

8th Early Alzheimer s Disease PowerPoint PPT Presentation

  • Updated On :
  • Presentation posted in: General

Download Presentation

8th Early Alzheimer s Disease

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


3. Reasons for the Name Change (MCI ?Early AD Symposium) Well…….., to get more: $$$$ from the Pharmaceutical Industry for supporting the Symposium (the FDA has not approved any medications for treatment of MCI) 2006:5 2007:5 2008:4 2009:1

4. MCI Symposium ? Early Alzheimer Disease Symposium Some alternative titles considered PreMCI Tea Party AD LiteTM Not The MCI Symposium ICpAD

5. Pharmaceutical Sponsorship of the Early AD Symposium (2010) 0 (It’s the economy, stupid!)

6. Other Reasons for the Name Change….. (MCI ?Early AD Symposium) The winning suggestion gets free registration for the 2011 ???? Symposium (i.e., whatever we decide to call it).

7. Stages of Cognitive /Functional Decline

8. Concordance between Informant Report and Neuropsychological Performance

10. American Journal of Geriatric Psych: 16 December 2009; doi: 10.1097/JGP.0b013e3181c534a0 Reliability and Validity of an Algorithm for the Diagnosis of Normal Cognition, Mild Cognitive Impairment, and Dementia: Implications for Multicenter Research Studies. Duara, Ranjan M.D.; Loewenstein, David A. Ph.D.; Greig, Maria M.D.; Acevedo, Amarilis Ph.D.; Potter, Elizabeth Ph.D.; Appel, Jason M.D.; Raj, Ashok M.D.; Schinka, John Ph.D.; Schofield, Elizabeth M.P.H.; Barker, Warren M.S.; Wu, Yougui Ph.D.; Potter, Huntington Ph.D.

11. Utility of Biomarkers for Dx and Staging AD

12. Known or Suspected Modulators of Decline

13. Goals of the 8th MCI Symposium, 2010 1. To review results of cross-sectional and longitudinal studies of PreMCI and PreClinical AD 2. To review methods, results and consider future directions in PreMCI Clinical Trials. 3. To review the role of PET biomarkers in assessing PreMCI and MCI states 4. To review neuropsychological classification of PreMCI and MCI states

14. Support Acknowledgements for the 8th MCI/Early AD Symposium, 2010

15. Travel Fellowship Awards Eleni N. Aretouli, PhD, The Johns Hopkins University School of Medicine, Baltimore, Maryland Rishi Bhalla, PhD, R. Psych.University of British Columbia Vancouver, British Columbia, Canada Beth Jerskey, Ph.D, Alpert Medical School of Brown University, Butler Hospital, Providence, Rhode Island Judit Subirana Mirete, PhD, Ramon Llull University Barcelona, Spain Ozioma C. Okonkwo, PhD, Johns Hopkins Medical Institutions, Baltimore, Maryland

16. Thank You Warren (Billy) Barker Yirah Ochoa Sheila Lucas, Tricia Murphy Charlene Welker The Staff of the Wien Center and the Florida ADRC Special thanks to David Perlman and Mr. & Mrs. Reichenstein for their generous donations

  • Login